Premium Reports
Contact KLAS
 Download Report Brief  Download Full Report    Zoom in charts

Preferences

   Bookmark

Related Series

Population Health Vendor Overview 2023
|
2023
Population Health Vendor Overview 2021
|
2021
Population Health Data Acquisition & Analysis 2020
|
2020
Population Health Care Management 2019
|
2019
Population Health Management 2018, Part 1
|
2019
Population Health Management 2018, Part 2
|
2019
Population Health Management 2017, Part 2
|
2018
Population Health Management 2017, Part 1
|
2017
Population Health Performance 2016
|
2017
Population Health Management 2015
|
2015
Population Health Performance
|
2014

Related Segments

 End chart zoom
Population Health Population Health
* A page refresh may be necessary to see the updated image

Population Health
Which Vendor Pioneers are Driving Outcomes?

author - Mark Allphin
Author
Mark Allphin
 
January 26, 2015 | Read Time: 2  minutes

A surge of population health management (PHM) vendors claims to meet common needs such as data aggregation, risk stratification, care management, and patient engagement. Yet with shifting market pressure and so many vendors entering the market, not all vendors have proven to deliver. Who are providers looking at to meet their needs and how are the vendors delivering? This report is a compilation of KLAS population health findings in 2014.

1. PHYTEL EMERGES AS AN EARLY LEADER

Phytel climbed to the top of the vendor hill in KLAS’ 2014 population health management performance report. Thanks to quick implementations, deep user deployment, and high provider satisfaction in all performance areas, Phytel has proven themselves able to meet many of their customers’ population health needs. 

How are other vendors performing? See the Population Health Performance 2014 report to find out.

phytel across the four pillarstangible benefits from phytel

2. TANGIBLE BENEFITS SEEN; COST SAVINGS YET TO COME

Of all the tangible benefits seen, cost savings—the primary incentive for taking on risk in accountable care arrangements—was the least achieved. While only 20% of surveyed providers reported cost savings, 70% reported some sort of tangible benefits including improved outcomes, better care, and improved prevention. Vendors with the highest percentage of respondents reporting such tangible benefits overall were Phytel, Wellcentive, and Explorys. 

To find out why, see the Population Health Performance 2014 report.

tangible benefits realized

3. ONE-STOP SHOP STILL A FANTASY

Though many providers want one comprehensive vendor solution that meets all of their PHM needs, that reality has not yet been realized. Few providers agree that a one-stop solution exists, and many providers are currently using multiple vendors to meet their needs. 

To find out which vendors are being utilized most heavily, and for what functions, see the Population Health 2014 Perception report.

one stop shop for phm

4. EMR CONSIDERATION DOES NOT YET EQUAL ADOPTION

EMR vendors are highly considered among providers for their future population health needs. However, best-of-breed vendors are more highly adopted since EMR vendors are still developing, implementing, and getting their products live in the PHM space. Some providers who want a one-stop shop hope that their EMR vendor will provide the PHM functionality they wish for. 

For an in-depth look at who is top of mind for providers and why, see the Population Health 2014 Perception report.

future considerations which vendors are you considering for the future

 Download Report Brief  Download Full Report

This material is copyrighted. Any organization gaining unauthorized access to this report will be liable to compensate KLAS for the full retail price. Please see the KLAS DATA USE POLICY for information regarding use of this report. © 2024 KLAS Research, LLC. All Rights Reserved. NOTE: Performance scores may change significantly when including newly interviewed provider organizations, especially when added to a smaller sample size like in emerging markets with a small number of live clients. The findings presented are not meant to be conclusive data for an entire client base.

​